Russian researchers develop breakthrough cat allergy vaccine
Russian scientists have developed a new vaccine designed to protect against cat allergy, one of the world's most ubiquitous types of hypersensitivity, Moscow's Sechenov University has announced.
The vaccine, created in cooperation with the Medical University of Vienna, is currently in the preparatory stage for human trials.
Allergies to cats – which can manifest with symptoms such as sneezing, coughing, chest tightness, shortness of breath, and itchy eyes and skin – affect up to 20% of the world's population, according to various studies.
The newly developed recombinant vaccine – the world's first for cat allergy – is expected to provide safer, more targeted treatment with fewer side effects than existing therapies, the researchers said.
Recombinant vaccines are made using a small, harmless part of the virus or allergen – usually a protein – which is produced in a lab, rather than being taken directly from the actual virus, bacteria, or allergen source.
The structure and development of a new class of recombinant vaccines were described by a group of scientists in an article published in the scientific journal Allergy in April.
Preclinical efficacy tests of the vaccine were conducted on rabbits. Scientists found that the vaccine stimulates the production of antibodies that block up to 85% of the allergic reaction triggered by cat allergens, the scientists said, adding that existing drugs used for allergen-specific immunotherapy (ASIT) showed weaker results during studies.
The researchers have selected the two most promising vaccine designs for cat allergy based on the results of the study, the press service of Sechenov First Moscow State Medical University said in a statement earlier this week.
'The allergies can be treated using ASIT – a method that involves introducing the allergen into the body – to gradually build up resistance to its effects. However, the ASIT drugs currently available are extract-based vaccines, meaning the allergens are directly derived from cat fur,' Aleksandr Karaulov, the head of the Department of Clinical Immunology and Allergology at Sechenov University, said.
He noted that it is difficult to maintain the correct dosage of the allergen in these types of vaccines, adding that they do not cover the full range of allergenic proteins, require multiple injections, and can cause allergic side effects.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Russia Today
3 days ago
- Russia Today
Major Russian city backs fines for promoting abortion
Lawmakers in the Russian city of St. Petersburg have advanced a bill that would impose fines on individuals and organizations that coerce women into having abortions. The Legislative Assembly passed the measure on Wednesday in its second reading. The legislation would penalize acts such as persuasion, bribery, deception or other pressure aimed at ending a pregnancy. Fines would range from 3,000 rubles ($40) for individuals to 50,000 rubles ($600) for officials and legal entities. Punishments can be imposed even if an abortion does not occur. Medical advice from a doctor based on social or health indications would not count as a violation. The bill's explanatory note says it aims to support family and motherhood and tackle Russia's demographic problems. According to Rosstat, the country recorded 1.22 million births in 2024, down 3.4% from 2023, making it the worst year since 1999. 'Our demography is at such a low level that… it's a number one problem,' said MP Pavel Krupnik, one of the sponsors of the bill. 'According to statistics, 500,000 abortions were performed in 2024, of which only 25% were for medical reasons. Just imagine what we're doing ourselves.' He added that many women lose the ability to have children after terminating a pregnancy. The bill still needs final approval in a third reading to become law. Similar measures have passed in more than ten Russian regions, including Bryansk, where a comparable law takes effect on September 1. Authorities in Murmansk and Pskov have proposed alternative legislation to fight abortions, suggesting paying doctors bonuses for persuading women to keep their pregnancies. St. Petersburg lawmakers are currently weighing draft amendments to the Social Code to offer payments to pregnant college students to discourage them from delaying childbirth. Abortions remain legal in Russia and are covered by national health insurance. Terminations are allowed up to 12 weeks on request, up to 22 weeks for social reasons, such as being the result of rape or in the case of death or disability of the husband, and at any stage for medical reasons. Russian Deputy Prime Minister Tatyana Golikova said in March that efforts to prevent abortion led to more than 37,000 women choosing to carry their pregnancies to term last year. Russian President Vladimir Putin has previously opposed banning abortions, instead emphasizing the importance of creating favorable economic and social conditions to encourage people to have larger families and increase the birth rate.
Russia Today
31-05-2025
- Russia Today
Passenger train derails after bridge collapse in Russia: Live updates
A bridge overpass collapsed onto railway tracks, causing a passenger train to derail in the western Russian region of Bryansk on Sunday. First responders are working to rescue people from the wreckage, with dozens reportedly injured. Multiple Telegram channels have claimed that the bridge was likely brought down by an act of sabotage.
Russia Today
18-05-2025
- Russia Today
Russian researchers develop breakthrough cat allergy vaccine
Russian scientists have developed a new vaccine designed to protect against cat allergy, one of the world's most ubiquitous types of hypersensitivity, Moscow's Sechenov University has announced. The vaccine, created in cooperation with the Medical University of Vienna, is currently in the preparatory stage for human trials. Allergies to cats – which can manifest with symptoms such as sneezing, coughing, chest tightness, shortness of breath, and itchy eyes and skin – affect up to 20% of the world's population, according to various studies. The newly developed recombinant vaccine – the world's first for cat allergy – is expected to provide safer, more targeted treatment with fewer side effects than existing therapies, the researchers said. Recombinant vaccines are made using a small, harmless part of the virus or allergen – usually a protein – which is produced in a lab, rather than being taken directly from the actual virus, bacteria, or allergen source. The structure and development of a new class of recombinant vaccines were described by a group of scientists in an article published in the scientific journal Allergy in April. Preclinical efficacy tests of the vaccine were conducted on rabbits. Scientists found that the vaccine stimulates the production of antibodies that block up to 85% of the allergic reaction triggered by cat allergens, the scientists said, adding that existing drugs used for allergen-specific immunotherapy (ASIT) showed weaker results during studies. The researchers have selected the two most promising vaccine designs for cat allergy based on the results of the study, the press service of Sechenov First Moscow State Medical University said in a statement earlier this week. 'The allergies can be treated using ASIT – a method that involves introducing the allergen into the body – to gradually build up resistance to its effects. However, the ASIT drugs currently available are extract-based vaccines, meaning the allergens are directly derived from cat fur,' Aleksandr Karaulov, the head of the Department of Clinical Immunology and Allergology at Sechenov University, said. He noted that it is difficult to maintain the correct dosage of the allergen in these types of vaccines, adding that they do not cover the full range of allergenic proteins, require multiple injections, and can cause allergic side effects.
